RPI-MN

N/A

Report date: 2022/08/10 15:46:23

Base Information

Drug NameRPI-MN
Drug Alias NamepepteronRPI-MN
ClassificationBiologics
Mechanisms of ActionInterferon gamma stimulantsMuscle-type nicotinic acetylcholine receptor antagonists
TargetsInterferon gammaMuscle-type nicotinic acetylcholine receptor
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesNutra PharmaBio Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZhongxin Dongtai(Laiyang) Nano & Gene Biotechnology Co LtdBio TherapeuticsNutra Pharma
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A